These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23020866)

  • 1. A multicentre study on high-frequency ultrasound evaluation of the skin and joints in patients with psoriatic arthritis treated with infliximab.
    De Agustín JJ; Moragues C; De Miguel E; Möller I; Acebes C; Naredo E; Uson J; Rejon E; Mayordomo L; Garrido J
    Clin Exp Rheumatol; 2012; 30(6):879-85. PubMed ID: 23020866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine profiles during infliximab monotherapy in psoriatic arthritis.
    Mastroianni A; Minutilli E; Mussi A; Bordignon V; Trento E; D'Agosto G; Cordiali-Fei P; Berardesca E
    Br J Dermatol; 2005 Sep; 153(3):531-6. PubMed ID: 16120138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a preliminary US power Doppler composite score for monitoring treatment in PsA.
    Gutierrez M; Di Geso L; Salaffi F; Bertolazzi C; Tardella M; Filosa G; Filippucci E; Grassi W
    Rheumatology (Oxford); 2012 Jul; 51(7):1261-8. PubMed ID: 22378715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab.
    Cauza E; Spak M; Cauza K; Hanusch-Enserer U; Dunky A; Wagner E
    Rheumatol Int; 2002 Nov; 22(6):227-32. PubMed ID: 12426660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients.
    Feletar M; Brockbank JE; Schentag CT; Lapp V; Gladman DD
    Ann Rheum Dis; 2004 Feb; 63(2):156-61. PubMed ID: 14722204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2.
    van der Heijde D; Kavanaugh A; Gladman DD; Antoni C; Krueger GG; Guzzo C; Zhou B; Dooley LT; de Vlam K; Geusens P; Birbara C; Halter D; Beutler A
    Arthritis Rheum; 2007 Aug; 56(8):2698-707. PubMed ID: 17665424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonographic wrist and hand abnormalities in early psoriatic arthritis patients: correlation with clinical, dermatological, serological and genetic indices.
    Bandinelli F; Denaro V; Prignano F; Collaku L; Ciancio G; Matucci-Cerinic M
    Clin Exp Rheumatol; 2015; 33(3):330-5. PubMed ID: 25797649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound composite scores for the assessment of inflammatory and structural pathologies in Psoriatic Arthritis (PsASon-Score).
    Ficjan A; Husic R; Gretler J; Lackner A; Graninger WB; Gutierrez M; Duftner C; Hermann J; Dejaco C
    Arthritis Res Ther; 2014 Oct; 16(5):476. PubMed ID: 25361855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonographic evaluation in psoriatic arthritis is of major importance in evaluating disease activity.
    Michelsen B; Diamantopoulos AP; Hammer HB; Soldal DM; Kavanaugh A; Haugeberg G
    Ann Rheum Dis; 2016 Dec; 75(12):2108-2113. PubMed ID: 27091837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study.
    Kampylafka E; d'Oliveira I; Linz C; Lerchen V; Stemmler F; Simon D; Englbrecht M; Sticherling M; Rech J; Kleyer A; Schett G; Hueber AJ
    Arthritis Res Ther; 2018 Jul; 20(1):153. PubMed ID: 30053825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab in psoriasis and psoriatic arthritis.
    Papoutsaki M; Osório F; Morais P; Torres T; Magina S; Chimenti S; Costanzo A
    BioDrugs; 2013 Jan; 27 Suppl 1():13-23. PubMed ID: 23990278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatoid hand joint synovitis: gray-scale and power Doppler US quantifications following anti-tumor necrosis factor-alpha treatment: pilot study.
    Ribbens C; André B; Marcelis S; Kaye O; Mathy L; Bonnet V; Beckers C; Malaise MG
    Radiology; 2003 Nov; 229(2):562-9. PubMed ID: 12970463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial.
    Torii H; Nakagawa H;
    J Dermatol Sci; 2010 Jul; 59(1):40-9. PubMed ID: 20547039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term infliximab therapy improves symptoms of psoriatic arthritis and decreases concentrations of cartilage oligomeric matrix protein.
    Cauza E; Hanusch-Enserer U; Frischmuth K; Fabian B; Dunky A; Kostner K
    J Clin Pharm Ther; 2006 Apr; 31(2):149-52. PubMed ID: 16635048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and ultrasonographic predictors for achieving minimal disease activity in patients with psoriatic arthritis: the UPSTREAM (Ultrasound in PSoriatic arthritis TREAtMent) prospective observational study protocol.
    Canzoni M; Piga M; Zabotti A; Scirè CA; Carrara G; Olivieri I; Iagnocco A
    BMJ Open; 2018 Jul; 8(7):e021942. PubMed ID: 29991631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis.
    Marzo-Ortega H; McGonagle D; Rhodes LA; Tan AL; Conaghan PG; O'Connor P; Tanner SF; Fraser A; Veale D; Emery P
    Ann Rheum Dis; 2007 Jun; 66(6):778-81. PubMed ID: 17185324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of trial data for infliximab and golimumab: baseline C-reactive protein level and prediction of therapeutic response in patients with psoriatic arthritis.
    Au SC; Ramirez-Fort MK; Gottlieb AB
    Arthritis Care Res (Hoboken); 2014 Jul; 66(7):1114-8. PubMed ID: 24339203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparity between ultrasound and clinical findings in psoriatic arthritis.
    Husic R; Gretler J; Felber A; Graninger WB; Duftner C; Hermann J; Dejaco C
    Ann Rheum Dis; 2014 Aug; 73(8):1529-36. PubMed ID: 23740228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis.
    Naredo E; Möller I; Cruz A; Carmona L; Garrido J
    Arthritis Rheum; 2008 Aug; 58(8):2248-56. PubMed ID: 18668537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.